NEXT
Sign in to follow

The Legal Intelligencer

Another Risperdal Case Tossed Midtrial

The Philadelphia judge did not explain his decision, but another lawsuit was tossed in December shortly after the defense started their case.
8 minute read

Litigation Daily

The Massive Accutane Litigation Just Fell Apart After Judge Boots Expert 'Hired Guns'

Any litigator knows a case can rise or fall on the testimony of an expert witness. A New Jersey state judge made that abundantly clear when he skewered the plaintiffs' two experts in a long-running fight over the acne drug Accutane, banning their testimony and handing a huge win to Hoffman La Roche and Covington & Burling.
6 minute read

The Legal Intelligencer

Pfizer Fails Second Bid to Escape Whistleblower Suit

After two attempts to get out of a whistleblower case, Pfizer is still on the hook for claims that it illegally marketed an anti-fungal medication, Vfend, for off-label use.
10 minute read

New Jersey Law Journal

Drugmaker Must Pay Opponents' Fees After Patent Suit Held 'Meritless'

Roxane Laboratories must pay legal fees and costs for two defendants after filing a patent infringement suit that was "exceptionally meritless," a federal judge in Newark has ruled.
10 minute read

Texas Lawyer

Led by Lanier, Tort Reform Foes Fete Republican Senator in Houston

Here's a political riddle: What does Republican U.S. Sen. Lindsey Graham of South Carolina have in common with Democratic-leaning plaintiff lawyers, including Lisa Blue, Mikal Watts, Bob Hilliard and Wayne Fisher?
5 minute read

Delaware Law Weekly

Bristol-Myers Squibb, Pfizer Unload Slew of Eliquis Infringement Cases

Bristol-Myers Squibb Co. and Pfizer Inc. on Monday filed a slew of patent infringement suits in Delaware to protect their patents for the successful drug Eliquis and halt the development of generic versions of the profitable blood thinner.
6 minute read

The Legal Intelligencer

EDPA Becomes Hub for Generic Drug Antitrust Litigation

A multidistrict antitrust litigation over the generic drugs Digoxin and Doxycycline has been significantly expanded to include numerous additional class action cases, all stemming from a wide-ranging federal probe that last year led two pharmaceutical executives to plead guilty to price-fixing charges.
7 minute read

The Legal Intelligencer

Xarelto Makers Want Plaintiffs' Litigation Funding Info

Defendant drug companies in the Xarelto mass tort want to know how the plaintiffs are funding their lawsuits.
3 minute read

New York Law Journal

Feds Accuse Shkreli, Ex-Counsel of 'Ramping Up' Row as Trial Strategy

A federal prosecutor in the securities fraud case against pharmaceutical executive Martin Shkreli and his ex-counsel Evan Greebel accused the defendants on Friday of strategically “ramping up” the animosity between them in an effort to sever their cases.
4 minute read

New York Law Journal

Shkreli and Ex-Counsel Seek Separate Trial Paths

As the fraud case against former pharmaceutical executive Martin Shkreli moves closer to trial, attorneys for the controversial "Pharma Bro" and for co-defendant Evan Greebel, Shkreli's former counsel, will argue Friday in the Eastern District of New York that they should be tried separately.
4 minute read

TRENDING STORIES

Law Pro Logo

Featured Firms

Law Offices of Gary Martin Hays & Associates, P.C.

(470) 294-1674

Law Offices of Mark E. Salomone

(857) 444-6468

Smith & Hassler

(713) 739-1250

More from ALM

More from ALM

Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

Resources

  • AI-Powered Deposition and Medical Record Summaries: Low Risk, High Reward

    Brought to you by Parrot

    Download Now

  • Aligning Client Needs with Lawyer Growth and Profitability

    Brought to you by BigHand

    Download Now

  • Technology to Make E-Discovery Smarter, Not Harder

    Brought to you by Nuix

    Download Now

  • Does Generative AI Have the Power to Transform Legal Services?

    Brought to you by HaystackID

    Download Now